BlackRock Fund Advisors - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$8,000
-11.1%
56,586
+28.1%
0.00%
Q3 2016$9,000
-10.0%
44,166
+11.7%
0.00%
Q2 2016$10,000
-16.7%
39,543
+8.0%
0.00%
Q1 2016$12,000
+9.1%
36,599
+24.0%
0.00%
Q4 2015$11,00029,5150.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$130,0000.07%
Benin Management CORP 83,000$72,0000.04%
CONDOR CAPITAL MANAGEMENT 114,987$100,0000.03%
FIRST NEW YORK SECURITIES LLC /NY 15,000$13,050,0000.01%
Advisory Services Network, LLC 22,000$19,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,000$157,0000.00%
Moors & Cabot, Inc. 25,000$22,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
Tower Research Capital LLC (TRC) 4,566$4,0000.00%
AQR Capital Management 213,900$186,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders